Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
Unitedhealth Group Inc (NYSE: UNH) closed the day trading at $311.38 down -17.79% from the previous closing price of $378.75. In other words, the price has decreased by -$17.79 from its previous closing price. On the day, 58.44 million shares were traded.
Ratios:
For a better understanding of UNH, let’s look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.86 whereas as Long-Term Debt/Eq ratio is at 0.75.
HSBC Securities Upgraded its Hold to Buy on January 10, 2025, while the target price for the stock was maintained at $595.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 17 ’25 when FLYNN TIMOTHY PATRICK bought 1,000 shares for $511.57 per share. The transaction valued at 511,575 led to the insider holds 4,500 shares of the business.
McSweeney Erin sold 701 shares of UNH for $438,987 on Nov 11 ’24. The EVP & Chief People Officer now owns 7,105 shares after completing the transaction at $626.23 per share. On Nov 11 ’24, another insider, McSweeney Erin, who serves as the Officer of the company, bought 701 shares for $626.23 each.
Valuation Measures:
As of this moment, Unitedhealth’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.02, and their Forward P/E ratio for the next fiscal year is 10.57. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.06. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.69 while its Price-to-Book (P/B) ratio in mrq is 2.98.
Stock Price History:
Over the past 52 weeks, UNH has reached a high of $630.73, while it has fallen to a 52-week low of $376.83. The 50-Day Moving Average of the stock is -35.05%, while the 200-Day Moving Average is calculated to be -42.20%.
Shares Statistics:
A total of 910.00M shares are outstanding, with a floating share count of 905.19M. Insiders hold about 0.21% of the company’s shares, while institutions hold 92.00% stake in the company.
Earnings Estimates
The dynamic stock of Unitedhealth Group Inc (UNH) is currently being evaluated by a team of 18.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is $6.31, with high estimates of $7.08 and low estimates of $5.12.
Analysts are recommending an EPS of between $26.32 and $22.08 for the fiscal current year, implying an average EPS of $25.22. EPS for the following year is $29.67, with 24.0 analysts recommending between $33.85 and $25.35.
Revenue Estimates
16 analysts predict $111.91B in revenue for the current quarter. It ranges from a high estimate of $115.54B to a low estimate of $110.09B. As of the current estimate, Unitedhealth Group Inc’s year-ago sales were $98.86BFor the next quarter, 16 analysts are estimating revenue of $113.95B. There is a high estimate of $116.47B for the next quarter, whereas the lowest estimate is $111.57B.
A total of 22 analysts have provided revenue estimates for UNH’s current fiscal year. The highest revenue estimate was $458.27B, while the lowest revenue estimate was $443.83B, resulting in an average revenue estimate of $450.6B. In the same quarter a year ago, actual revenue was $400.28BBased on 23 analysts’ estimates, the company’s revenue will be $486.38B in the next fiscal year. The high estimate is $503.31B and the low estimate is $472.33B.
